Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023 : 2023-12-09
±³À°ÀÏÀÚ : 2023-12-09
±³À°Àå¼Ò : ½ÅÃÌ ¼¼ºê¶õ½ºº´¿ø Á¾ÇÕ°ü 337È£
±³À°ÁÖÁ¦ : Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023
ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
´ã´çÀÚ : ±è¼Ò¿¬
¿¬¶ôó : 070-4105-5373
À̸ÞÀÏ : sykim1212@yuhs.ac
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:00~09:20 A Journey Through Time: Understanding the Evolution of Clinical Features in Pulmonary Hypertension Stephan Rosenkranz(Heart Center at the University of Cologne)
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:20~09:40 Key Considerations in Diagnosing and Managing Pulmonary Hypertension in the Elderly Á¤ÀÎÇö(¿ëÀμ¼ºê¶õ½ºº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:40~10:00 From Guidelines to Practice: How Recent Guidelines Reflect Changes in Pulmonary Hypertension ¹ÚÀçÇü(Ãæ³²´ëº´¿ø )
Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:00~10:30 Åä·Ð(Session 1. Evolution of PH patients & clinical practice in PH) ³ªÁø¿À, ¹è´ëȯ, ±è¾ç±â, Àü°æ¸¸(°í´ë±¸·Îº´¿ø, ÃæºÏ´ëº´¿ø, ¼øõÇâ´ë ¼¿ïº´¿ø, »ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:30~10:50 ÈÞ½Ä ()
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:50~11:20 How to differentiate between Group 1 (PAH with lung disease) and Group 3 (PH due to lung disease) Marc Humbert(Faculte du Medecine-Universite Paris-Saclay)
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 11:20~11:40 Management of Pulmonary Hypertension in Interstitial Lung Disease Patients: When to Evaluate, How to Treat? ¹Ú¹«¼®(¼¼ºê¶õ½ºº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 11:40~12:00 Sleep-related breathing disorder, Obesity and Pulmonary hypertension °ÁöÀº(ÀÏ»ê¹éº´¿ø )
Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 12:00~12:30 Åä·Ð(Session 2. When patients have PH and lung disease) Çã¶õ, ÃÖÁ¤Çö, ÀåÇ×Á¦, ¹ÚÁö¸í(ÇѾç´ëº´¿ø, ºÎ»ê´ëº´¿ø, ÇØ¿î´ëº´¿ø, ¼¿ï´ëº´¿ø)
½Ä»ç 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 12:30~13:30 ½Ä»ç ()
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 13:30~14:00 How to differentiate between Group 1 (PAH with heart disease) and Group 2 ¼Áö¿ø(°³²¼¼ºê¶õ½ºº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:00~14:20 Management of PH with Heart failure À±Á¾Âù(¼¿ï¼º¸ðº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:20~14:40 Key Considerations in PH patients with valvular heart disease ±è´ëÈñ(¼¿ï¾Æ»êº´¿ø )
Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:40~15:10 Åä·Ð(Session 3. When patients have PH and heart disease) ¼±º´ÁÖ, ±è¹Ì³ª, ±è¼öÇö, ȲÇå±Ô(¼¿ï¾Æ»êº´¿ø, °í´ë¾È¾Ïº´¿ø, ¼¿ïÀÇ·á¿ø, ¼øõÇâ´ë ±¸¹Ìº´¿ø)
ÈÞ½Ä 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:10~15:30 ÈÞ½Ä ()
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:30~15:45 Case from Asan Medical Center °µµÀ±(¼¿ï¾Æ»êº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:45~16:00 Case from Samsung Medical Center ±èÁöÈÆ(»ï¼º¼¿ïº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:00~16:15 Case from Seoul Nat ¹ÚÁØ¿ø(¼¿ï´ëº´¿ø )
±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:15~16:30 Case from Severance Hospital ¿ì¾Æ¶ó(¼¼ºê¶õ½ºº´¿ø )
Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:30~17:00 Åä·Ð(Session 4. Interactive Case Discussion) Á¤¹ÌÇâ, ÀÌÁÖÈñ, ³ª½Â¿ø, ÃÖ¿øÀÏ(¼¿ï¼º¸ðº´¿ø, ÃæºÏ´ëº´¿ø, ¿ï»ê´ëº´¿ø, ¸íÁöº´¿ø)